• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

传统定量吸入器与新型呼吸驱动装置的给药错误

Administration errors with a conventional metered dose inhaler versus a novel breath actuated device.

作者信息

Larsen J S, Hahn M, Kochevar J W, Morris R J, Kaiser H B, Weisberg S C, Halverson P C, Quessy S N

机构信息

College of Pharmacy, University of Minnesota, Minneapolis.

出版信息

Ann Allergy. 1993 Aug;71(2):103-6.

PMID:8346860
Abstract

Metered dose inhalers are difficult for patients to use. A device that eliminates coordination and timing of actuation may simplify the use of metered dose inhalers. This trial compared (1) number of errors made and (2) specific errors made between the conventional press and breathe metered dose inhaler (MDI) and the novel breath actuated Autohaler inhalation device in 24 subjects. We studied the use of each device in 12 patients trained and experienced in using an MDI and in 12 volunteers who had never been exposed to any inhalation device. We observed that even experienced patients continue to have difficulty with the coordination and timing of metered dose inhalers. The volunteer group had equal difficulty with both devices but it appeared that it was easier for them to learn how to use the breath actuated device than the MDI.

摘要

定量吸入器对患者来说使用困难。一种消除启动时协调和计时的装置可能会简化定量吸入器的使用。本试验比较了24名受试者使用传统按压并呼吸的定量吸入器(MDI)和新型呼吸启动的自动吸入器时(1)出现的错误数量以及(2)出现的具体错误。我们研究了12名接受过MDI使用培训且有经验的患者以及12名从未接触过任何吸入装置的志愿者对每种装置的使用情况。我们观察到,即使是有经验的患者在定量吸入器的协调和计时方面仍然存在困难。志愿者组使用两种装置时遇到的困难相同,但似乎他们学习如何使用呼吸启动装置比学习使用MDI更容易。

相似文献

1
Administration errors with a conventional metered dose inhaler versus a novel breath actuated device.传统定量吸入器与新型呼吸驱动装置的给药错误
Ann Allergy. 1993 Aug;71(2):103-6.
2
Inhaler technique in older people in the community.社区中老年人的吸入器使用技巧。
Age Ageing. 2004 Mar;33(2):185-8. doi: 10.1093/ageing/afh062.
3
Inhaled corticosteroid delivery systems: clinical role of a breath-actuated device.吸入性皮质类固醇给药系统:一种呼吸驱动装置的临床作用
Eur Rev Med Pharmacol Sci. 2001 Jan-Feb;5(1):7-16.
4
How to achieve good compliance and adherence with inhalation therapy.如何实现良好的吸入治疗依从性和持续性。
Curr Med Res Opin. 2005;21 Suppl 4:S33-7. doi: 10.1185/030079905X61776.
5
The technology of metered-dose inhalers and treatment costs in asthma: a retrospective study of breath actuation versus traditional press-and-breathe inhalers.定量吸入器技术与哮喘治疗费用:呼吸驱动型与传统按压式吸入器的回顾性研究
Clin Ther. 1999 Jan;21(1):236-53. doi: 10.1016/S0149-2918(00)88281-8.
6
Inhalatory therapy training: a priority challenge for the physician.吸入疗法培训:医师面临的一项首要挑战。
Acta Biomed. 2007 Dec;78(3):233-45.
7
[Effect of a spacer device used with metered dose inhaler].[与定量吸入器一起使用的间隔装置的效果]
Nihon Kyobu Shikkan Gakkai Zasshi. 1990 Nov;28(11):1415-20.
8
The evolution of inhaler technology.吸入器技术的演变。
J Asthma. 1994;31(1):55-64. doi: 10.3109/02770909409056770.
9
A cost-effectiveness analysis of breath-actuated metered-dose inhalers.呼吸驱动定量吸入器的成本效益分析
Manag Care Interface. 1997 Sep;10(9):99-107.
10
Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.丙酸倍氯米松超细微粒吸入器(每日400微克)与布地奈德干粉吸入器(每日800微克)治疗哮喘的对比
Int J Clin Pract. 2001 Mar;55(2):100-6.

引用本文的文献

1
A review of ipratropium bromide/fenoterol hydrobromide (Berodual) delivered via Respimat Soft Mist Inhaler in patients with asthma and chronic obstructive pulmonary disease.一项关于通过Respimat软雾吸入器递送的异丙托溴铵/氢溴酸非诺特罗(倍氯米松)用于哮喘和慢性阻塞性肺疾病患者的综述。
Drugs. 2004;64(15):1671-82. doi: 10.2165/00003495-200464150-00005.
2
Evaluating the outcome of two teaching methods of breath actuated inhaler in an inner city asthma clinic.在内城区哮喘诊所评估两种呼吸驱动吸入器教学方法的效果。
J Med Syst. 1999 Oct;23(5):349-56. doi: 10.1023/a:1020525116505.
3
Zafirlukast. A review of its pharmacology and therapeutic potential in the management of asthma.
扎鲁司特。对其药理学及在哮喘治疗中的潜在应用的综述。
Drugs. 1998 Jan;55(1):121-44. doi: 10.2165/00003495-199855010-00008.